Moderna doesn’t expect to have clinical trial data on its coronavirus vaccine in young children until 2022, CEO Stephane Bancel said Monday.
Moderna’s vaccine has been authorized by the Food and Drug Administration for use in people who are 18 years old and older. Clinical trial studies testing the vaccine in kids, whose immune systems can respond differently than adults, still need to be completed.
The company has already begun a study testing the vaccine in adolescents as young as 12, and Bancel expects that study will be done by the time the fall semester starts in September. It expects to start a study for young children between ages 1 and 11 “soon,” but Bancel said that study will take “much longer.” Read more…..
Chart of the Day
The US is facing an aging population, falling birth rate and economic recession caused by the coronavirus pandemic. These issues will have huge implications on the size of the workforce and the consumer base.